Invasive coronary function testing in patients with INOCA: Three medications
| Drug administered | Results | Diagnosis |
|---|---|---|
| 1. Adenosine | Coronary flow reserve < 2.5 | Nonendothelial-dependent microvascular dysfunction |
| 2. Acetylcholine | < 50% increase in coronary blood flow | Endothelial-dependent microvascular dysfunction |
| < 5% increase in coronary artery diameter | Endothelial-dependent macrovascular dysfunction | |
| > 90% decrease in coronary artery diameter Chest pain and ischemic ST-segment changes on electrocardiography | Epicardial coronary spasm | |
| Chest pain and ischemic ST-segment changes on electrocardiography in the absence of significant epicardial coronary vasoconstriction | Microvascular coronary spasm | |
| 3. Nitroglycerin | < 20% increase in coronary artery diameter | Nonendothelial-dependent macrovascular dysfunction |
INOCA = ischemia and no obstructive coronary artery disease (ie, < 50% stenosis)